Related Experiment Videos
[Lung transplant therapy for suppurative diseases]
A de Pablo1, S López, P Ussetti
1Servicio de Neumología. Clínica Puerta de Hierro. Madrid. España. alic1575@separ.es
Archivos De Bronconeumologia
|May 28, 2005
Summary
Lung transplantation offers good survival rates for patients with bronchiectasis, even with airway colonization. This study compared outcomes for cystic fibrosis patients versus those with other causes of bronchiectasis.
Area of Science:
- Pulmonary Medicine
- Transplant Surgery
- Infectious Disease
Context:
- Bronchiectasis is a chronic lung condition often leading to severe respiratory compromise.
- Lung transplantation is a viable treatment option for advanced bronchiectasis.
- Understanding outcomes in different etiologies of bronchiectasis is crucial for patient selection and management.
Purpose:
- To evaluate lung transplantation outcomes in patients with bronchiectasis.
- To compare results between patients with cystic fibrosis and those with bronchiectasis from other causes.
- To analyze pre- and post-transplant characteristics, including microbiology and survival.
Summary:
- A retrospective study analyzed 171 lung transplant recipients with suppurative lung disease (27 cystic fibrosis, 17 other causes).
- Pre-transplant lung function showed severe obstruction and insufficiency. Post-transplant, 91% had airway colonization, with Pseudomonas spp. in 64%.
- One-year survival was 79%, five-year survival was 49%, with no significant differences based on cystic fibrosis or Pseudomonas colonization.
Impact:
- Lung transplantation provides good survival for bronchiectasis patients despite challenges like airway colonization.
- Findings support lung transplantation as an effective therapy for severe bronchiectasis regardless of etiology.
- Management of airway colonization is important for optimizing post-transplant care.